Gastroparesis Trial, Recruiting NCT06854120 Sponsor: University of Auckland, New Zealand Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT06854120
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You have been diagnosed with gastroparesis (a condition where the stomach empties too slowly) and/or functional dyspepsia (ongoing stomach discomfort without a clear physical cause)
  • You have been prescribed a medication to help with stomach movement or to manage your symptoms as part of your regular care
  • You are able to have a Body Surface Gastric Mapping (BSGM) recording — a non-invasive test that measures stomach activity — both before and during your treatment
  • You are able to understand and sign a consent form agreeing to have two BSGM recordings taken

Who may not be able to join:

  • You are under 18 years of age
  • You have had previous surgery on your esophagus (food pipe) or stomach (note: appendix removal or gallbladder removal are still allowed)
  • You have a history of skin allergies or are known to be very sensitive to cosmetics or lotions
  • You are currently pregnant
  • You are a prisoner, have a known cognitive (thinking or memory) impairment, or currently live in an institutionalized setting (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Henry Parkman, MD, Temple University

Phone: +64 9 373 7599

Australian sites

Western Sydney University, Sydney, New South Wales
+61 2 4634 4579

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Auckland, New Zealand
Registry
ClinicalTrials.gov
Start date
26 February 2025
Est. completion
26 February 2028

Where this trial is recruiting

🇦🇺 Australia 🇳🇿 New Zealand 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in overall postprandial BSGM Gastric Alimetry Rhythm Index (minimum: 0; maximum: 1) on treatment compared to baseline (with a lower score meaning worse outcome).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov